FDA.reportPublic FDA data

Viri Sode

Product NDC
83027-0150
11-digit product format
830270150
Labeler code
83027
Product ID
83027-0150_aa330e58-bbfc-474e-8d9e-31d649bfe238
Type
HUMAN OTC DRUG
Nonproprietary name
Cytomegalovirus Nosode, Herpes Simplex I Nosode, Herpes Simplex II Nosode, Influenzinum (2024-2025), Rubella Nosode, Hepatitis A Nosode, Hepatitis B Nosode, Hepatitis C Nosode, Epstein Barr Virus Nosode, Herpes Zoster Nosode
Dosage form
SPRAY
Route
ORAL
Labeler
Nutritional Specialties, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
2025-06-03
Marketing end
2030-05-07
Substance
HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE; RUBELLA VIRUS
Active strength
30; 30; 30; 16; 16; 15; 15; 16; 15; 15; 15; 15; 16 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL
NDC exclude flag
No
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Viri Sode

Active Ingredients#

Ingredient, Strength table
IngredientStrength
HUMAN HERPESVIRUS 516 [hp_X]/mL
HUMAN HERPESVIRUS 116 [hp_X]/mL
HUMAN HERPESVIRUS 216 [hp_X]/mL
INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)15 [hp_C]/mL
INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)15 [hp_C]/mL
INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE15 [hp_C]/mL
INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE15 [hp_C]/mL
RUBELLA VIRUS16 [hp_X]/mL
HEPATITIS A VIRUS30 [hp_X]/mL
HEPATITIS B VIRUS30 [hp_X]/mL
HEPATITIS C VIRUS30 [hp_X]/mL
HUMAN HERPESVIRUS 415 [hp_C]/mL
HUMAN HERPESVIRUS 315 [hp_C]/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 13 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
7COI029E6KInternal UNII lookup
22G38P19RLInternal UNII lookup
74J6DNH49UInternal UNII lookup
AU5C98U4BBInternal UNII lookup
6TU4EY6UNWInternal UNII lookup
CYK5P89K8XInternal UNII lookup
PS2DCE2WVFInternal UNII lookup
U751HEX436Internal UNII lookup
G54MT8V18GInternal UNII lookup
77H9EM77P7Internal UNII lookup
QI56415283Internal UNII lookup
2A26YW7PNXInternal UNII lookup
9885M7D6JPInternal UNII lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
cab3c0e1-6358-45e9-ac26-a51b4d4a7af8Available on FDA.report

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
83027-0150-1Viri Sode60 mL in 1 BOTTLE, SPRAYSPRAY602

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Viri SodeCYTOMEGALOVIRUS NOSODE, HERPES SIMPLEX I NOSODE, HERPES SIMPLEX II NOSODE, INFLUENZINUM (2024-2025), RUBELLA NOSODE, HEPATITIS A NOSODE, HEPATITIS B NOSODE, HEPATITIS C NOSODE, EPSTEIN BARR VIRUS NOSODE, HERPES ZOSTER NOSODENutritional Specialties, Inc.cab3c0e1-6358-45e9-ac26-a51b4d4a7af82026-05-12WarningsExact identifier
ndc (product): 83027-0150

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
83027-0150-18302701500160 mL in 1 BOTTLE, SPRAY (83027-0150-1) 60 ml2025-06-032030-05-07NoNoHistorical